ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China flag China · Delayed Price · Currency is CNY
49.82
+0.62 (1.26%)
May 30, 2025, 2:45 PM CST
133.46%
Market Cap 22.29B
Revenue (ttm) 1.20B
Net Income (ttm) -583.96M
Shares Out 449.03M
EPS (ttm) -1.29
PE Ratio n/a
Forward PE 112.84
Dividend 0.21 (0.39%)
Ex-Dividend Date Jun 3, 2024
Volume 18,196,516
Average Volume 12,512,741
Open 47.50
Previous Close 49.20
Day's Range 47.50 - 55.33
52-Week Range 12.74 - 55.33
Beta 0.67
RSI 67.98
Earnings Date Aug 29, 2025

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical drugs. Its pediatric medicines include fuganlin and yiqi jianpi oral liquid, carboxymestrine oral solution, and xiaoer kechuanling oral liquid products; and clindamycin hydrochloride palmitate dispersible tablet, acetylguitaricin dry suspension, qinxiangqingjie oral liquid, levocetirizine hydrochloride drop, epstein hydrochloride granule, clindamycin hydrochloride palmitate granule, clindamycin... [Read more]

Sector Healthcare
Founded 2002
Employees 1,484
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300723
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.